Could AI and ultrasound replace unnecessary breast biopsies?
NCT ID NCT06171607
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether contrast-enhanced ultrasound (CEUS) combined with machine learning can more accurately tell if a breast mass is benign or malignant. 100 women with suspicious breast masses will receive CEUS with a contrast agent. The goal is to see if this approach can reduce the need for invasive biopsies by correctly identifying benign masses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Contrast-enhanced ultrasound with perflutren lipid microspheres or sulfur hexafluoride lipid microspheres
What this could lead to
If successful, this could provide a more accurate, non-invasive way to diagnose breast masses, potentially sparing many women from unnecessary biopsies.
What could go wrong
This is an early Phase 1 study with only 100 participants, so results may not apply to all patients. The machine learning model may not perform as well in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Los Angeles County-USC Medical Center
RECRUITINGLos Angeles, California, 90033, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
USC / Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••